[Experience in the use of large single doses of sarcolysine in oncological practice].
D000293:Adolescent; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D014067:Tonsillar Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D008558:Melphalan
Opyt ispol'zovaniia bol'shikh razovykh doz sarkolizina v onkologicheskoĭ praktike.